Clinical Trial Update: Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in Children [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing cyclophosphamide to mycophenolate mofetil for steroid-dependent idiopathic nephrotic syndrome in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Nephrotic Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Idiopathic Nephrotic Syndrome | Phase 3 | Status: COMPLETED